99.0% PURITY LOT VL-2920-A NAD+
A high-capacity 500 mg lyophilized vial of nicotinamide adenine dinucleotide for extended research into cellular energy and longevity pathways.
- 1 × NAD+ 500mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
About this compound
A high-capacity 500 mg lyophilized vial of nicotinamide adenine dinucleotide for extended research into cellular energy and longevity pathways.
- 500 mg lyophilized coenzyme per vial
- Essential redox coenzyme (NAD+/NADH)
- ≥99% purity
- High capacity for extended research protocols
Why the lot matters
- Synthesized and tested per lot, never as a production-run average
- Certificate of Analysis published before the lot goes on sale
- Independent lab, contractually separate from manufacturing
What "research use only" means
This product is sold exclusively for in-vitro laboratory research. It is not evaluated by any medicines agency and is not intended for human or animal administration, diagnosis, treatment, or prevention of disease.
Technical data
Current lot snapshot
Shipping
Reported use in research
NAD+ (nicotinamide adenine dinucleotide) is a vital coenzyme essential for metabolism and cellular function, mediating redox reactions for energy production across more than 500 enzymatic pathways. This high-capacity 500 mg vial supports extended research into energy metabolism, DNA repair, and the sirtuin and PARP systems involved in aging.
Reported findings
NAD+ research links the coenzyme to muscle function, neuronal protection, and the mitigation of cellular aging via sirtuin and PARP activity. Larger quantities are useful where higher cumulative exposure or repeated dosing is required across longer experimental timelines.
Handling & safety
Rapid administration of NAD+ has been associated with transient flushing or chest tightness in research settings, typically reduced by slower delivery. As a naturally occurring coenzyme its general tolerability is favorable; formal safety characterization continues.
Reconstitution
Recommended ratio
- 10 mL of bacteriostatic water per 500 mg vial
- Equivalent to 50 mg/mL (i.e. 5 mg per 10 units on a 100 U insulin syringe)
- Remove the plastic flip-off lid from the vial.
- Disinfect the rubber stoppers with alcohol wipes.
- Inject the diluent slowly down the inner wall of the vial to avoid foaming.
- Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.
Storage
Unopened / before reconstitution
- Store at a stable temperature.
- Stable for 24 months.
- For long-term storage (2+ years), store at -20 °C.
Reconstituted solution
- Must be kept refrigerated.
- Avoid exposure to light and excessive heat.
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 663.43 g/mol | PASS |
| Purity | HPLC (area %) | 99.0% | PASS |
| Net peptide content | Gravimetric | 499.00 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 663.43 g/mol | PASS |
| Purity | HPLC (area %) | 99.1% | PASS |
| Net peptide content | Gravimetric | 498.50 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with 663.43 g/mol | PASS |
| Purity | HPLC (area %) | 99.2% | PASS |
| Net peptide content | Gravimetric | 498.00 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
| Lot | Filled | Purity | Report | Status | |
|---|---|---|---|---|---|
| VL-2920-A | Jul 2026 | 99.0% | TR-88374 | Active | |
| VL-2939-B | May 2026 | 99.1% | TR-88307 | Sold out | |
| VL-2958-C | Mar 2026 | 99.2% | TR-88316 | Sold out |
